ID LN-464 AC CVCL_3962 SY LN 464; LN464 DR BTO; BTO_0004451 DR BioSample; SAMN10988403 DR cancercelllines; CVCL_3962 DR Cell_Model_Passport; SIDM00058 DR Cosmic; 849873 DR Cosmic; 2367498 DR Cosmic; 2516032 DR DepMap; ACH-000676 DR PharmacoDB; LN464_848_2019 DR Wikidata; Q54902786 RX PubMed=7693337; RX PubMed=8509230; RX PubMed=10416987; RX PubMed=22570425; RX PubMed=25984343; RX PubMed=31068700; WW Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx CC Problematic cell line: Contaminated. The STR profile of ACN and LN-464 are identical. SNP analysis (DepMap) also shows identity of both cell lines. Personal communication of Hegi, Monika E. confirms the mismatch between the STR profile of this cell line and of the patient from which LN-464 was established. We believe this is a melanoma cell line based on the RNASeq expression profile of LN-464 (DepMap) which clusters with that of melanoma patient samples. The presence of the BRAF V600E while present at low frequency in gliomas is also a hallmark of melanomas. Originally thought to originate from the brain right parieto-occipital lobe of a 67 year old male patient with a glioblastoma. CC Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). CC Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00624. CC Population: Caucasian. CC Doubling time: 35 hours (PubMed=25984343). CC Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (DepMap=ACH-000676). CC Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asn184fs*6 (c.545_546insA); Zygosity=Heterozygous (PubMed=10416987; DepMap=ACH-000676). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe113Ser (c.338T>C); ClinVar=VCV000823709; Zygosity=Homozygous (PubMed=10416987; DepMap=ACH-000676). CC Omics: Genomics; Whole exome sequencing. CC Omics: Phenotyping; shRNA library screening. ST Source(s): PubMed=22570425 ST Amelogenin: X ST CSF1PO: 11 ST D13S317: 11,13 ST D16S539: 11 ST D18S51: 16 ST D21S11: 28 ST D3S1358: 16 ST D5S818: 12 ST D7S820: 10,13 ST D8S1179: 12,13 ST FGA: 22 ST Penta D: 9 ST Penta E: 10,14 ST TH01: 9 ST TPOX: 9,12 ST vWA: 14,17,18 DI NCIt; C3224; Melanoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) OI CVCL_1068 ! ACN SX Sex unspecified AG Age unspecified CA Cancer cell line DT Created: 04-04-12; Last updated: 14-08-25; Version: 27 // RX PubMed=10416987; DOI=10.1111/j.1750-3639.1999.tb00536.x; PMCID=PMC8098486; RA Ishii, Nobuaki RA Maier, Daniel RA Merlo, Adrian RA Tada, Mitsuhiro RA Sawamura, Yutaka RA Diserens, Annie-Claire RA Van Meir, Erwin G. RT "Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor RT suppressor genes in human glioma cell lines."; RL Brain Pathol. 9:469-479(1999). // RX PubMed=31068700; DOI=10.1038/s41586-019-1186-3; PMCID=PMC6697103; RA Ghandi, Mahmoud RA Huang, Franklin W. RA Jane-Valbuena, Judit RA Kryukov, Gregory V. RA Lo, Christopher C. RA McDonald, E. Robert 3rd RA Barretina, Jordi Ginesta RA Gelfand, Ellen T. RA Bielski, Craig M. RA Li, Hao-Xin RA Hu, Kevin RA Andreev-Drakhlin, Alexander Y. RA Kim, Jaegil RA Hess, Julian M. RA Haas, Brian J. RA Aguet, Francois RA Weir, Barbara A. RA Rothberg, Michael V. RA Paolella, Brenton R. RA Lawrence, Michael Scott RA Akbani, Rehan RA Lu, Yi-Ling RA Tiv, Hong L. RA Gokhale, Prafulla C. RA de Weck, Antoine RA Mansour, Ali Amin RA Oh, Coyin RA Shih, Juliann RA Hadi, Kevin RA Rosen, Yanay RA Bistline, Jonathan RA Venkatesan, Kavitha RA Reddy, Anupama RA Sonkin, Dmitriy RA Liu, Manway RA Lehar, Joseph RA Korn, Joshua M. RA Porter, Dale A. RA Jones, Michael D. RA Golji, Javad RA Caponigro, Giordano RA Taylor, Jordan E. RA Dunning, Caitlin M. RA Creech, Amanda L. RA Warren, Allison C. RA McFarland, James M. RA Zamanighomi, Mahdi RA Kauffmann, Audrey RA Stransky, Nicolas RA Imielinski, Marcin RA Maruvka, Yosef E. RA Cherniack, Andrew D. RA Tsherniak, Aviad RA Vazquez, Francisca RA Jaffe, Jacob D. RA Lane, Andrew Alan RA Weinstock, David M. RA Johannessen, Cory M. RA Morrissey, Michael P. RA Stegmeier, Frank RA Schlegel, Robert RA Hahn, William Chun RA Getz, Gad RA Mills, Gordon B. RA Boehm, Jesse S. RA Golub, Todd Robert RA Garraway, Levi Alexander RA Sellers, William Raj RT "Next-generation characterization of the Cancer Cell Line RT Encyclopedia."; RL Nature 569:503-508(2019). // RX PubMed=22570425; DOI=10.1093/neuonc/nos072; PMCID=PMC3367844; RA Bady, Pierre RA Diserens, Annie-Claire RA Castella, Vincent RA Kalt, Stefanie RA Heinimann, Karl RA Hamou, Marie-France RA Delorenzi, Mauro RA Hegi, Monika E. RT "DNA fingerprinting of glioma cell lines and considerations on RT similarity measurements."; RL Neuro-oncol. 14:701-711(2012). // RX PubMed=7693337; RA Li, Hong RA Hamou, Marie-France RA de Tribolet, Nicolas RA Jaufeerally, Rebana RA Hofmann, Martin RA Diserens, Annie-Claire RA Van Meir, Erwin G. RT "Variant CD44 adhesion molecules are expressed in human brain RT metastases but not in glioblastomas."; RL Cancer Res. 53:5345-5349(1993). // RX PubMed=25984343; DOI=10.1038/sdata.2014.35; PMCID=PMC4432652; RA Cowley, Glenn S. RA Weir, Barbara A. RA Vazquez, Francisca RA Tamayo, Pablo RA Scott, Justine A. RA Rusin, Scott RA East-Seletsky, Alexandra RA Ali, Levi D. RA Gerath, William F.J. RA Pantel, Sarah E. RA Lizotte, Patrick Hall RA Jiang, Guo-Zhi RA Hsiao, Jessica RA Tsherniak, Aviad RA Dwinell, Elizabeth RA Aoyama, Simon RA Okamoto, Michael RA Harrington, William RA Gelfand, Ellen T. RA Green, Thomas M. RA Tomko, Mark J. RA Gopal, Shuba RA Wong, Terence C. RA Li, Hu-Bo RA Howell, Sara RA Stransky, Nicolas RA Liefeld, Ted RA Jang, Dongkeun RA Bistline, Jonathan RA Meyers, Barbara Hill RA Armstrong, Scott Allen RA Anderson, Kenneth Carl RA Stegmaier, Kimberly RA Reich, Michael RA Pellman, David RA Boehm, Jesse S. RA Mesirov, Jill P. RA Golub, Todd Robert RA Root, David E. RA Hahn, William Chun RT "Parallel genome-scale loss of function screens in 216 cancer cell RT lines for the identification of context-specific genetic RT dependencies."; RL Sci. Data 1:140035.1-140035.12(2014). // RX PubMed=8509230; DOI=10.1002/ijc.2910540329; RA Rimoldi, Donata RA Romero, Pedro RA Carrel, Stefan RT "The human melanoma antigen-encoding gene, MAGE-1, is expressed by RT other tumour cells of neuroectodermal origin such as glioblastomas and RT neuroblastomas."; RL Int. J. Cancer 54:527-528(1993). //